SETIAWAN, S. I. and ASCOBAT, P. (2019) “ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA”, International Journal of Applied Pharmaceutics, 11(6), pp. 80–83. doi: 10.22159/ijap.2019.v11s6.33551.